Perspective Therapeutics Inc Reports Q3 2026: Net Loss of $32. ...

GuruFocus | Nov 9, 2026 6:10 PM EST

Cash Position Strengthens to $202 Million as Radiopharmaceutical Pipeline Advances Toward Key Clinical Milestones Related Stocks: CATX ,